Olema Pharmaceuticals, Inc. (OLMA) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Join SI Premium – FREE
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.61), $0.06 worse than the analyst estimate of ($0.55).
For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crude Inventory Fell 0.9 Million Barrels Last Week - EIA
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
- Berkshire Hathaway hits 52-week high on election rally
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
